← 產業報告目錄
Phage Therapy Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Route of Administration (Oral, Topical, Rectal Route, Intravenous Route), by Targeted Bacteria (Escherichia coli, Staphylococcus aureus, Streptococcus, Pseudomonas aeruginosa, Salmonella, Other Bacteria), by Disease Indication (Urinary Tract Infections, Chronic Otitis, Dental Extraction, Chronic Ulcerative Colitis, Bone Infection, Wound and Skin Infections, Cystic Fibrosis, Other Disease Indications), Region And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-03頁數 180報告編號 INSIGHTACE-99adb83c7c
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Industry analysis indicates the Phage Therapy Market globally will advance at a 20.50% CAGR during 2025–2034.
At its core, Phage Therapy pertains to key industry insights & findings from the report:
The expanding number of people living with infectious illnesses is expected to fuel the growth of this market. Stakeholders across the healthcare landscape are expandingly turning to these solutions to meet contemporary demands.
The market's upward path is underpinned by expanding healthcare spending, technological evolution, and the expanding focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Phage Therapy Market Snapshot
Chapter 4. Global Phage Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Route of Administration, Estimates & Trend Analysis
5.1. By Route of Administration, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Route of Administration:
5.2.1. Oral
5.2.2. Topical
5.2.3. Rectal Route
5.2.4. Intravenous Route
Chapter 6. Market Segmentation 2: By Distribution Channel Estimates & Trend Analysis
6.1. By Distribution Channel & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Distribution Channel:
6.2.1. Hospital Pharmacies
6.2.2. Retail Pharmacies
6.2.3. Online Pharmacies
Chapter 7. Market Segmentation 3: By Targeted Bacteria Estimates & Trend Analysis
7.1. By Targeted Bacteria & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Targeted Bacteria:
7.2.1. Escherichia coli
7.2.2. Staphylococcus aureus
7.2.3. Streptococcus
7.2.4. Pseudomonas aeruginosa
7.2.5. Salmonella
7.2.6. Other Bacteria
Chapter 8. Market Segmentation 3: By Disease Indication Estimates & Trend Analysis
8.1. By Disease Indication & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Disease Indication:
8.2.1. Urinary Tract Infections
8.2.2. Chronic Otitis
8.2.3. Dental Extraction
8.2.4. Chronic Ulcerative Colitis
8.2.5. Bone Infection
8.2.6. Wound and Skin Infections
8.2.7. Cystic Fibrosis
8.2.8. Other Disease Indications
Chapter 9. Phage Therapy Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Route of Administration, 2021-2034
9.1.2. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
9.1.3. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
9.1.4. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
9.1.5. North America Phage Therapy Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Phage Therapy Market revenue (US$ Million) By Route of Administration, 2021-2034
9.2.2. Europe Phage Therapy Market revenue (US$ Million) By Distribution Channel, 2021-2034
9.2.3. Europe Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
9.2.4. Europe Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
9.2.5. Europe Phage Therapy Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Phage Therapy Market revenue (US$ Million) By Route of Administration, 2021-2034
9.3.2. Asia Pacific Phage Therapy Market revenue (US$ Million) By Distribution Channel, 2021-2034
9.3.3. Asia Pacific Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
9.3.4. Asia Pacific Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
9.3.5. Asia Pacific Phage Therapy Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Phage Therapy Market revenue (US$ Million) By Route of Administration, (US$ Million) 2021-2034
9.4.2. Latin America Phage Therapy Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2021-2034
9.4.3. Latin America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
9.4.4. Latin America Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
9.4.5. Latin America Phage Therapy Market revenue (US$ Million) by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Phage Therapy Market revenue (US$ Million) By Route of Administration, (US$ Million) 2021-2034
9.5.2. Middle East & Africa Phage Therapy Market revenue (US$ Million) By Distribution Channel, (US$ Million) 2021-2034
9.5.3. Middle East & Africa Phage Therapy Market revenue (US$ Million) estimates and forecasts By Targeted Bacteria, 2021-2034
9.5.4. Middle East & Africa Phage Therapy Market revenue (US$ Million) estimates and forecasts By Disease Indication, 2021-2034
9.5.5. Middle East & Africa Phage Therapy Market revenue (US$ Million) by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Armata Pharmaceuticals, Inc.
10.2.2. BiomX (MBcure Ltd.)
10.2.3. Eligo Bioscience
10.2.4. Intralytix, Inc.
10.2.5. iNtODEWorld
10.2.6. Locus Biosciences
10.2.7. MicroPhage, Inc.
10.2.8. TechnoPhage
10.2.9. Microgen Russia
10.2.10. Aumed
10.2.11. Aziya immunopreparat LLC
10.2.12. Sensei Biotherapeutics
10.2.13. Eliava BioPreparations
10.2.14. Nextbiotics
10.2.15. PhagePro,
10.2.16. Nexabiome
10.2.17. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們